Rilpivirine Plasma and Cervico-Vaginal Concentrations in Women During Pregnancy and Postpartum.
Eke AC, Chakhtoura N, Kashuba A, et al
J Acquir Immune Defic Syndr. 2018 Mar 8
Abstract

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.
Osiyemi O, Yasin S, Zorrilla C, et al   
Infect Dis Ther. 2018 Jan 15
Abstract

Lowered rilpivirine exposure during third trimester of pregnancy in HIV-1-positive women.
Schalkwijk S, Colbers A, Konopnicki D, et al  
Clin Infect Dis. 2017 Jun 8.
Abstract

FULL-TEXT ARTICLE
Negative Regulation of Human Pregnane X Receptor by MicroRNA-18a-5p: Evidence for Suppression of MicroRNA-18a-5p Expression by Rifampin and Rilpivirine.
Sharma D, Turkistani AA, Chang W, et al
Mol Pharmacol. 2017 Apr 13
Paper

Etravirine and Rilpivirine drug resistance among HIV-1 subtype C infected Children failing non -nucleoside reverse transcriptase inhibitor-based regimens in South India.
Saravanan S, Kausalya B, Gomathi S, et a
AIDS Res Hum Retroviruses. 2016 Nov 21.
Abstract

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.
Tran AH, Best BM, Stek A, et al
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):289-96.
Abstract

FULL-TEXT ARTICLE
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.
Mandelbrot L, Duro D, Belissa E, Peytavin G.
Antimicrob Agents Chemother. 2015 Sep;59(9):5869
Paper

Rilpivirine resistance associated mutations in HIV-1 infected pregnant women.
Cecchini DM, Zapiola I, Rodriguez CG, Bouzas MB.
Enferm Infecc Microbiol Clin. 2015 Jan 29
Abstract